CVS HEALTH Corp — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2019-02-28

Reporting Person: Hourican Kevin (EVP & President, CVS Pharmacy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Stock	F	4489	$57.83	Disposed	311	Direct
2019-02-28	Common Stock	A	9467	$57.83	Acquired	9778	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (restricted)	9355	Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

F2: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.